Former FDA chief Scott Gottlieb on JNJ’s application for emergency use authorization

Former FDA chief Scott Gottlieb on JNJ’s application for emergency use authorization

Johnson & Johnson applied for an emergency use authorization from the Food and Drug Administration for its coronavirus vaccine after releasing data last week showing it was about 66% effective in protecting against the virus. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joined “Squawk Box” on Friday to discuss.

More News Stories

Loading...

More Political News

Loading...